latest news stock values companies glp-1 obesity cardiometabolic How to Invest in Drugs: Stocks and Funds to Watch How Big Is The Weight

B., & Jadhav, S

7, 24 July 2017, p

Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a persons overall risk of developing the disease

Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides

They can be interpreted as the average number of T2D patients who would need to be treated with a GLP-1RA relative to insulin for a given follow-up period of time to prevent one case with a clinical outcome of interest

Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect (Review)